Article

Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma

2023-08-16

Abstract excerpt

<title>Abstract</title> <p>Multiple Myeloma is an incurable plasma cell malignancy with a poor survival rate that is usually treated with immunomodulatory drugs (iMiDs) and proteosome inhibitors (PIs). The malignant plasma cells quickly become resistant to these agents causing relapse and uncontrolled growth of resistant clones. From whole genome sequencing (WGS) and RNA sequencing (RNA-seq) studies, different hi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 98267c8b-a33d-56af-8640-b65b50f1301a
DOI: 10.21203/rs.3.rs-3221549/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myelomaDOI 10.21203/rs.3.rs-3221549/v1Read

1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma.Semantic proximity Read

Establishment and characterization of multiple myeloma cell lines from a single patient’s disease course immortalizes clonal heterogeneitySemantic proximity Read

Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns.Semantic proximity Read

Co-evolution of tumor and immune cells during progression of multiple myeloma.Semantic proximity Read

Multiple Myeloma DREAM Challenge Reveals Epigenetic Regulator <i>PHF19</i> As Marker of Aggressive DiseaseSemantic proximity Read

Integrative multi-omics identifies high risk Multiple Myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathwaysSemantic proximity Read

Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myelomaSemantic proximity Read

Genomic Basis of Multiple Myeloma Subtypes from the MMRF CoMMpass StudySemantic proximity Read

Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targetsSemantic proximity Read

Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple MyelomaSemantic proximity Read

Genomic and transcriptional profiling stratifies VQ myeloma lines into two clusters with distinct risk signatures and drug responsesSemantic proximity Read